Skip to main content
Benjamin Chong, MD, Dermatology, Dallas, TX

BenjaminChongMD

Dermatology Dallas, TX

Assistant Professor, Dermatology, University of Texas Southwestern Medical Center, Southwestern Medical School

Dr. Chong is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Chong's full profile

Already have an account?

  • Office

    5939 Harry Hines Blvd
    Dallas, TX 75390
    Phone+1 214-645-2400
    Fax+1 214-645-2405

Education & Training

  • Henry Ford Health/Henry Ford Hospital
    Henry Ford Health/Henry Ford HospitalResidency, Dermatology, 2005 - 2008
  • Trinity Health Ann Arbor Hospital
    Trinity Health Ann Arbor HospitalInternship, Internal Medicine, 2004 - 2005
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 2004

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2008 - 2026
  • MI State Medical License
    MI State Medical License 2004 - 2008
  • American Board of Dermatology Dermatology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
  • Fellow (FAAD) American Academy of Dermatology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Mock Recruitment for the Study of Antimalarials in Incomplete Lupus Erythematosus Trial  
    Benjamin F Chong, Cristina Arriens, David R Karp, Judith A James, Arthritis Care & Research

Lectures

  • Complex Medical Dermatology Cases 
    American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/4/2019
  • Dermatologists to the Rescue 
    American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/1/2019

Press Mentions

  • Horizon Therapeutics Plc Announces First Patient Enrolled in Phase 2 Trial Evaluating Daxdilimab for the Treatment of Discoid Lupus Erythematosus
    Horizon Therapeutics Plc Announces First Patient Enrolled in Phase 2 Trial Evaluating Daxdilimab for the Treatment of Discoid Lupus ErythematosusJanuary 4th, 2023
  • Reviewers' List December 2017
    Reviewers' List December 2017October 3rd, 2017
  • Clinical Clues Separate Cutaneous Lupus, Dermatomyositis
    Clinical Clues Separate Cutaneous Lupus, DermatomyositisMarch 16th, 2016

Professional Memberships